(Yesterday we highlighted a Reuter’s article that proposed that the lack of funding and drug development for ME/CFS constituted a ‘market failure’. Today we hit back on this market failure with a call for a congressional hearing that asks why the FDA...
We just saw Esther, an ME/CFS patient make dramatic improvement not just in her gut but in her decades-long problems with extreme fatigue, cognition, orthostatic intolerance and mood by treating her small intestinal bacterial overgrowth (SIBO) with an antibiotic...
A BIG thanks to everyone whose contributions helped make Health Rising's summer drive a success :)
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.